Acadia Healthcare (ACHC) Reports In-Line Q2 EPS, SSS Rose 5.2%

Go back to Acadia Healthcare (ACHC) Reports In-Line Q2 EPS, SSS Rose 5.2%

Acadia Healthcare (ACHC) PT Maintained at $48 at Stephens on 2Q Report; 'Sell Off Overdone'

August 1, 2018 7:27 AM EDT

Stephens maintained its price target on Acadia Healthcare (NASDAQ: ACHC) at $48.00 while maintaining a Overweight rating, following the company's second quarter earnings report.

Analyst Dana Hambly suggests the sell-off in shares ACHC is overdone, as the company reported second quarter earnings per share... More

Stephens Reiterated Overweight on Acadia Healthcare (ACHC) Following 2Q

August 1, 2018 7:13 AM EDT

Stephens reiterated an Overweight rating and $48.00 price target on Acadia Healthcare (NASDAQ: ACHC) following the company's 2Q earnings report. U.S. revenues came in at $487.5 million missing the consensus of $494.7 million. SS revenue growth of 5.0% was driven by a 1.9% increase in SS... More

BMO Capital Downgrades Acadia Healthcare (ACHC) to Market Perform

August 1, 2018 5:43 AM EDT

BMO Capital downgraded Acadia Healthcare (NASDAQ: ACHC) from Outperform to Market Perform with a price target of $40.00 (from $45.00).

For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.

Shares of Acadia Healthcare closed at $39.48 yesterday.

... More